NL192521C - Glycerolderivaten die een ammoniumgroep bevatten met werking tegen de bloedplaatjes activerende factor en farmaceutische preparaten die dergelijke derivaten bevatten. - Google Patents

Glycerolderivaten die een ammoniumgroep bevatten met werking tegen de bloedplaatjes activerende factor en farmaceutische preparaten die dergelijke derivaten bevatten. Download PDF

Info

Publication number
NL192521C
NL192521C NL8801484A NL8801484A NL192521C NL 192521 C NL192521 C NL 192521C NL 8801484 A NL8801484 A NL 8801484A NL 8801484 A NL8801484 A NL 8801484A NL 192521 C NL192521 C NL 192521C
Authority
NL
Netherlands
Prior art keywords
formula
group
paf
heptadecyl
methyl
Prior art date
Application number
NL8801484A
Other languages
English (en)
Dutch (nl)
Other versions
NL192521B (nl
NL8801484A (nl
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NL8801484A publication Critical patent/NL8801484A/nl
Publication of NL192521B publication Critical patent/NL192521B/xx
Application granted granted Critical
Publication of NL192521C publication Critical patent/NL192521C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NL8801484A 1987-06-12 1988-06-09 Glycerolderivaten die een ammoniumgroep bevatten met werking tegen de bloedplaatjes activerende factor en farmaceutische preparaten die dergelijke derivaten bevatten. NL192521C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8713745 1987-06-12
GB878713745A GB8713745D0 (en) 1987-06-12 1987-06-12 Aminoacylates of glycerol

Publications (3)

Publication Number Publication Date
NL8801484A NL8801484A (nl) 1989-01-02
NL192521B NL192521B (nl) 1997-05-01
NL192521C true NL192521C (nl) 1997-09-02

Family

ID=10618794

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8801484A NL192521C (nl) 1987-06-12 1988-06-09 Glycerolderivaten die een ammoniumgroep bevatten met werking tegen de bloedplaatjes activerende factor en farmaceutische preparaten die dergelijke derivaten bevatten.

Country Status (33)

Country Link
US (1) US4921865A (ko)
JP (1) JPH0615540B2 (ko)
KR (1) KR960005153B1 (ko)
AR (1) AR245121A1 (ko)
AT (1) AT396236B (ko)
AU (1) AU621298B2 (ko)
BE (1) BE1000700A4 (ko)
CA (1) CA1337297C (ko)
CH (1) CH674516A5 (ko)
DE (1) DE3819829C2 (ko)
DK (1) DK319188A (ko)
DZ (1) DZ1215A1 (ko)
ES (1) ES2009283A6 (ko)
FI (1) FI90421C (ko)
FR (2) FR2616326B1 (ko)
GB (1) GB8713745D0 (ko)
GR (1) GR1000889B (ko)
HK (1) HK77191A (ko)
IE (1) IE61447B1 (ko)
IN (1) IN172782B (ko)
IT (1) IT1218067B (ko)
LU (1) LU87235A1 (ko)
MA (1) MA21298A1 (ko)
MY (1) MY103577A (ko)
NL (1) NL192521C (ko)
NO (1) NO170632C (ko)
NZ (1) NZ224936A (ko)
OA (1) OA08879A (ko)
PT (1) PT87689B (ko)
SE (1) SE466450B (ko)
SG (1) SG73191G (ko)
TN (1) TNSN88057A1 (ko)
ZA (1) ZA884024B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2556849B2 (ja) * 1986-02-13 1996-11-27 三共株式会社 グリセリン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035178A (en) * 1976-08-31 1977-07-12 Fmc Corporation Herbicidal 1,3-dioxanes
IN146343B (ko) * 1976-08-31 1979-05-05 Fmc Corp
US4375474A (en) * 1982-02-11 1983-03-01 Syntex (U.S.A.) Inc. Dioxalane containing imidazole compounds, compositions and use
GB8612940D0 (en) * 1986-05-28 1986-07-02 Dow Chemical Co Derivative esters

Also Published As

Publication number Publication date
HK77191A (en) 1991-10-11
FR2616326B1 (fr) 1989-12-01
DZ1215A1 (fr) 2004-09-13
AU621298B2 (en) 1992-03-12
FI882705A (fi) 1988-12-13
PT87689B (pt) 1992-09-30
IN172782B (ko) 1993-11-27
SE8802162D0 (sv) 1988-06-09
DK319188A (da) 1989-02-03
ES2009283A6 (es) 1989-09-16
NZ224936A (en) 1990-03-27
FI90421B (fi) 1993-10-29
GR1000889B (el) 1993-03-16
KR960005153B1 (ko) 1996-04-22
KR890000471A (ko) 1989-03-14
SG73191G (en) 1991-11-22
NL192521B (nl) 1997-05-01
CH674516A5 (ko) 1990-06-15
FR2616432B1 (fr) 1990-05-11
DK319188D0 (da) 1988-06-10
DE3819829A1 (de) 1988-12-22
DE3819829C2 (de) 1993-10-21
PT87689A (pt) 1988-07-01
AT396236B (de) 1993-07-26
TNSN88057A1 (fr) 1990-07-10
GB8713745D0 (en) 1987-07-15
ZA884024B (en) 1989-02-22
JPH0615540B2 (ja) 1994-03-02
SE8802162L (sv) 1988-12-13
ATA152988A (de) 1992-11-15
FR2616432A1 (fr) 1988-12-16
NO882564L (no) 1988-12-13
IE881752L (en) 1988-12-12
SE466450B (sv) 1992-02-17
AU1756288A (en) 1988-12-15
JPS6413085A (en) 1989-01-17
IT8820940A0 (it) 1988-06-10
BE1000700A4 (fr) 1989-03-14
MY103577A (en) 1993-08-28
GR880100363A (en) 1989-03-08
NO882564D0 (no) 1988-06-10
CA1337297C (en) 1995-10-10
US4921865A (en) 1990-05-01
OA08879A (fr) 1989-10-31
MA21298A1 (fr) 1988-12-31
FI90421C (fi) 1994-02-10
NL8801484A (nl) 1989-01-02
IT1218067B (it) 1990-04-12
NO170632C (no) 1992-11-11
IE61447B1 (en) 1994-11-02
AR245121A1 (es) 1993-12-30
NO170632B (no) 1992-08-03
FR2616326A1 (fr) 1988-12-16
FI882705A0 (fi) 1988-06-08
LU87235A1 (fr) 1988-12-13

Similar Documents

Publication Publication Date Title
CA1297102C (en) Phospholipid derivatives, their production and use
US4910206A (en) 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists
US4845129A (en) Diaryl substituted cyclopentane and cyclopentene derivatives
NL192521C (nl) Glycerolderivaten die een ammoniumgroep bevatten met werking tegen de bloedplaatjes activerende factor en farmaceutische preparaten die dergelijke derivaten bevatten.
EP0178261A2 (en) Substituted 2-furanyl or 5-oxo-2-furanyl-alkoxy phosphoryl alkyl cyclimmonium salts
US4992428A (en) 5-aryl-substituted-2,3-dihydro-imidazo[1,2-a]furo- and thieno pyridines
US5134151A (en) 2-picolylamine derivatives
CA1261844A (en) 3-(n-alkylcarbamoyloxy)-2-alkyloxypropyl-2- substituted ethyl phosphate compounds
US5070139A (en) 2,4-disubstituted 1,3-dioxolanes
KR960005152B1 (ko) 신규 5-(ω-암모니아실옥시메틸렌)테트라히드로푸란 및 테트라 히드로티오펜
JPH05194524A (ja) 血栓症および血管痙攣症の治療に有用な７−オキサビシクロヘプチル置換複素環式アミドプロスタグランジン類縁体
CA1085856A (en) Pyrrolidine and piperidine prostaglandin analogues
GB2205833A (en) Aminoacylates of glycerol acetal
US5124334A (en) Benzylalcohol phospholipase A2 inhibitors
JPH0588713B2 (ko)
EP0127930A2 (en) Aminocyclopentane esters and their preparation and pharmaceutical formulation
US4201864A (en) Oxy-alkylamino acids and esters
JP2721178B2 (ja) フェノール誘導体
US4177283A (en) Aromatic prostaglandin analogues
US5141932A (en) 5-Aryl-substituted-2,3-dihydro-imidazo(1,2-a)furo- and thieno pyridines
EP0100527A1 (de) 4H-1,4-Benzothiazine zur Verwendung als Arzneimittel
JPH03106872A (ja) １―置換フェニル―４―ピリジルフタラジン誘導体
US4870098A (en) Antagonists of leukotriene D4
JPH0687745A (ja) 血小板活性化因子拮抗剤
JPH06500789A (ja) イミダゾール誘導体、それらの製造方法および医薬組成物

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 19990101